Industry: Healthcare
Published Date: May-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 170
Report ID: PMRREP25228
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Disease Epidemiology (2019)
3.2. Patient Treatment Journey
3.3. Phototherapy Treatment Patterns
3.4. Procedure Volume of Cosmetic Therapies
4. Key Success Factors
4.1. Recent Product Launches
4.2. Regulatory Scenario
4.3. Disease Epidemiology For Actinic Keratosis & Basal Cell Carcinoma (2019)
4.4. Strategic Promotional Strategies, By Manufacturers
5. Global Photodynamic Therapy Market - Pricing Analysis
5.1. Regional Pricing Analysis By Product Type
5.2. Global Average Pricing Analysis Benchmark
6. Global Photodynamic Therapy Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031
6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Market Background
7.1. Macro-Economic Factors
7.1.1. Global GDP Growth Outlook
7.1.2. Global Healthcare Industry Outlook
7.2. Forecast Factors - Relevance & Impact
7.2.1. Recent Product Launches
7.2.2. Prevalence of Skin Disorders and Cancer
7.2.3. Adoption of Photodynamic Therapy For Skin and Cancer Treatment
7.2.4. Top Companies Historical Growth
7.2.5. Per Capita Healthcare Expenditure In Different Economies
7.3. Market Dynamics
7.3.1. Drivers
7.3.2. Restraints
7.3.3. Opportunity Analysis
8. Global Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024-2031, by Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019-2023
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2024-2031
8.3.1. Photosensitizer Drugs
8.3.1.1. Hematoporphyrin derivative (HpD)
8.3.1.2. Aminolevulinic acid (ALA)
8.3.1.3. Benzoporphyrin derivative (BPD)
8.3.1.4. Texaphyrins
8.3.1.5. Chlorins
8.3.1.6. Dyes
8.3.2. Devices
8.3.2.1. Disposable Fiberoptic Light Delivery Devices
8.3.2.2. Diode Laser
8.4. Market Attractiveness Analysis By Product Type
9. Global Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024-2031, by Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2031
9.3.1. Basal Cell Carcinoma
9.3.2. Actinic Keratosis
9.3.3. Others
9.3.3.1. Psoriasis
9.3.3.2. Acne
9.3.3.3. Rosacea
9.3.3.4. Non-Small Cell Lung Cancer
9.3.3.5. Esophageal Cancer
9.3.3.6. Ophthalmology
9.4. Market Attractiveness Analysis By Application
10. Global Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024-2031, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2031
10.3.1. Hospitals
10.3.2. Private Dermatology Clinics
10.3.3. Laser Therapy Centers
10.3.4. Cancer Treatment Centers
10.3.5. Spas and Rejuvenation Centers
10.4. Market Attractiveness Analysis By End User
11. North America Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024-2031
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
11.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
11.4.1. By Country
11.4.1.1. U.S.
11.4.1.2. Canada
11.4.2. By Product Type
11.4.3. By Application
11.4.4. By End User
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Product Type
11.5.3. By Application
11.5.4. By End User
11.6. Market Trends
12. Latin America Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024-2031
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
12.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
12.4.1. By Country
12.4.1.1. Brazil
12.4.1.2. Mexico
12.4.1.3. Rest of Latin America
12.4.2. By Product Type
12.4.3. By Application
12.4.4. By End User
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By Application
12.5.4. By End User
12.6. Market Trends
13. Europe Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024-2031
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
13.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
13.4.1. By Country
13.4.1.1. Germany
13.4.1.2. Italy
13.4.1.3. France
13.4.1.4. U.K.
13.4.1.5. Spain
13.4.1.6. Russia
13.4.1.7. Poland
13.4.1.8. Rest of Europe
13.4.2. By Product Type
13.4.3. By Application
13.4.4. By End User
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By Application
13.5.4. By End User
13.6. Market Trends
14. South Asia Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024-2031
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
14.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
14.4.1. By Country
14.4.1.1. India
14.4.1.2. Thailand
14.4.1.3. Indonesia
14.4.1.4. Malaysia
14.4.1.5. Rest of South Asia
14.4.2. By Product Type
14.4.3. By Application
14.4.4. By End User
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By Application
14.5.4. By End User
14.6. Market Trends
15. East Asia Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024-2031
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
15.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.2. By Product Type
15.4.3. By Application
15.4.4. By End User
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By Application
15.5.4. By End User
15.6. Market Trends
16. Oceania Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024-2031
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
16.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
16.4.1. By Country
16.4.1.1. Australia
16.4.1.2. New Zealand
16.4.2. By Product Type
16.4.3. By Application
16.4.4. By End User
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By Application
16.5.4. By End User
16.6. Market Trends
17. Middle East and Africa Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024-2031
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
17.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. South Africa
17.4.1.3. Rest of Middle East and Africa
17.4.2. By Product Type
17.4.3. By Application
17.4.4. By End User
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product Type
17.5.3. By Application
17.5.4. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. Emerging Countries Photodynamic Therapy Market Analysis 2019-2023 and Forecast 2024-2031
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. China Photodynamic Therapy Market Analysis
18.2.1. Introduction
18.2.2. Market Value Proportion Analysis by Market Taxonomy
18.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.2.3.1. By Product Type
18.2.3.2. By End User
18.2.3.3. By Application
18.3. South Korea Photodynamic Therapy Market Analysis
18.3.1. Introduction
18.3.2. Market Value Proportion Analysis by Market Taxonomy
18.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.3.3.1. By Product Type
18.3.3.2. By End User
18.3.3.3. By Application
18.4. Russia Photodynamic Therapy Market Analysis
18.4.1. Introduction
18.4.2. Pricing Analysis
18.4.3. PEST Analysis
18.4.4. Market Value Proportion Analysis by Market Taxonomy
18.4.5. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.4.5.1. By Product Type
18.4.5.2. By End User
18.4.5.3. By Application
18.4.6. South Korea Photodynamic Therapy Market - Competition Landscape
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive (Photosensitizer Drug Manufactures)
19.3.1. Galderma S.A.
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Profitability by Market Segments (Product/Channel/Region)
19.3.1.4. Sales Footprint
19.3.1.5. Strategy Overview
19.3.1.5.1. Marketing Strategy
19.3.1.5.2. Product Strategy
19.3.1.5.3. Channel Strategy
19.3.2. Sun Pharmaceutical Industries Ltd.
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Profitability by Market Segments (Product/Channel/Region)
19.3.2.4. Sales Footprint
19.3.2.5. Strategy Overview
19.3.2.5.1. Marketing Strategy
19.3.2.5.2. Product Strategy
19.3.2.5.3. Channel Strategy
19.3.3. Biofrontera
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Profitability by Market Segments (Product/Channel/Region)
19.3.3.4. Sales Footprint
19.3.3.5. Strategy Overview
19.3.3.5.1. Marketing Strategy
19.3.3.5.2. Product Strategy
19.3.3.5.3. Channel Strategy
19.3.4. Novartis AG
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Profitability by Market Segments (Product/Channel/Region)
19.3.4.4. Sales Footprint
19.3.4.5. Strategy Overview
19.3.4.5.1. Marketing Strategy
19.3.4.5.2. Product Strategy
19.3.4.5.3. Channel Strategy
19.3.5. Allergan Plc
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Profitability by Market Segments (Product/Channel/Region)
19.3.5.4. Sales Footprint
19.3.5.5. Strategy Overview
19.3.5.5.1. Marketing Strategy
19.3.5.5.2. Product Strategy
19.3.5.5.3. Channel Strategy
19.4. Competition Deep Dive (PDT Device Manufactures)
19.4.1. Valeant Pharmaceuticals International, Inc.
19.4.1.1. Overview
19.4.1.2. Product Portfolio
19.4.1.3. Profitability by Market Segments (Product/Channel/Region)
19.4.1.4. Sales Footprint
19.4.1.5. Strategy Overview
19.4.1.5.1. Marketing Strategy
19.4.1.5.2. Product Strategy
19.4.1.5.3. Channel Strategy
19.4.2. Quest Pharmatech, Inc.
19.4.2.1. Overview
19.4.2.2. Product Portfolio
19.4.2.3. Profitability by Market Segments (Product/Channel/Region)
19.4.2.4. Sales Footprint
19.4.2.5. Strategy Overview
19.4.2.5.1. Marketing Strategy
19.4.2.5.2. Product Strategy
19.4.2.5.3. Channel Strategy
19.4.3. Hologic, Inc. (Cynosure Inc.)
19.4.3.1. Overview
19.4.3.2. Product Portfolio
19.4.3.3. Profitability by Market Segments (Product/Channel/Region)
19.4.3.4. Sales Footprint
19.4.3.5. Strategy Overview
19.4.3.5.1. Marketing Strategy
19.4.3.5.2. Product Strategy
19.4.3.5.3. Channel Strategy
20. Assumptions and Acronyms Used
21. Research Methodology